Back to search

Article

Beneficial changes in the gut microbiome of patients with multiple sclerosis after consumption of Neu-REFIX B-glucan in a clinical trial

2023-09-08

Abstract excerpt

<h4>Background</h4> Multiple sclerosis (MS) is a debilitating demyelinating disease and recent evidences are giving cues towards correlation of disease severity to gut microbiome dysbiosis. However, there haven’t been any reported interventions that beneficially modifies the gut microbiome to yield a clinically discernible improvement. Having earlier reported the clinical effects of a biological response modifier...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ee7eaaea-c5e4-5e89-b7ca-07e39096669b
DOI
10.1101/2023.09.07.23295172
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Beneficial changes in the gut microbiome of patients with multiple sclerosis after consumption of Neu-REFIX B-glucan in a clinical trialDOI 10.1101/2023.09.07.23295172
Select a neighboring publication to make it the new centre.